Unique formula that creates a physical barrier proven to block COVID-19, colds and flu on-sale November 2022
BioSure Global, the team behind the first CE marked HIV self-test, is launching BioSURE PRO Protective Nasal Spray - proven, safe and effective for 6-hours per use, the spray creates an physical barrier that helps prevent infections caused by rotavirus A (sickness and diarrhoea) RSV (common colds), influenzas (flu) and coronaviruses including COVID-19, before they even start.
This innovative, patented Nasal Spray has a unique action which creates a barrier in the nasopharynx that blocks the attachment of airborne viruses. BioSURE PRO Protective Nasal Spray coats the nasal membranes and forms a film to create an invisible, physical barrier that stops colds, flus and coronaviruses from attaching to the cells in your nose. If the viruses can’t connect, they can’t infect.
Suitable for daily use, for all aged 12 and over, BioSURE PRO costs just £14.95 and is proven to be effective for 6 hours per application and can be reapplied every 6 hours for continuous protection. With 400 sprays per bottle, it means there is 3 months supply if used daily, which equates to only 2.5p/hour of protection. BIOSURE PRO is not a medicine and uses natural and food safe ingredients means it is safe for prolonged daily use, with no side effects or risk of long term dependencies. Available online at www.bebiosure.com, on Amazon and from Well Pharmacy.
Clinical studies have demonstrated BioSURE PRO’s ability to stop viruses before they gain entry to the body, by blocking viral attachment to the nasopharynx. Independently tested against most common flus, colds and COVID-19 delta and omicron variants BioSURE PRO prevented viral replication in cells treated with the spray vs a control group of untreated cells. Four times more subjects remained infection-free after a 6-day study period with testing against Delta variant specifically.
 A Randomized, Double-Blind, Multi-Center Study to Evaluate the Efficacy and Safety of Ethyl Lauroyl Arginate Hydrochloride (ELAH) Formulation Versus a Matching Placebo Formulation Administered as a Nasal Spray to Reduce Viral Load From Nasal Area of Subjects with Coronavirus Disease 2019, Salvacion USA Inc, October 2021 (Study no: SLV-CV19-SPRAY).
Evaluation of the Efficacy of ELAH-COVIXYL-V against in vivo transmission of SARS-CoV-2, BioQual Inc., February 2021 (Study no: SALV-20-01A and SALV-20-02).
Demonstration of Effectiveness of a Nasal Spray to Form a Barrier Against Viral Infection, Perfectus BioMed Group, June 2021 (Study no: PB616-001-Phase-1 and 2a).
Demonstration of Effectiveness of a Placebo to Form a Barrier Against Viral Infection, Perfectus BioMed Group, November 2021 (Study no: PB616-002).
Covixyl-V Physicochemical Characterization, Nanotechnology Characterization Laboratory (Study no: NCL202108C).|Covixyl-V Pharmacokinetics, Nanotechnology Characterization Laboratory (Study no: NCL202108D
According to BioSURE Global CEO Brigette Bard this is a game changer in keeping the country moving as we move into the winter virus season and are all feeling the pinch of the economic crisis: “the last few years of COVID have been tough enough and now there is talk of a ‘tripledemic’, we need as many tools as possible to keep us all functioning physically and mentally! Nobody has time to get ill and have time off work, especially at this time of year. We have always been passionate about giving people products so they can feel in control and BioSURE PRO is effective at blocking the 3 ‘tripledemic’ viruses RSV, flu and COVID-19. Really we are looking at a behavioural change with people taking action before they catch an infection rather than reacting when they have symptoms”
Dr Abdul Gaffar, lead of the award winning team of scientists that developed the formula stated, “BioSURE PRO’s unique formula contains ELAH (Ethyl Lauroyl Arginate HCL), which prevents the virus from attaching to the nasal passages — essentially stopping the virus before it can reach a dangerous level. When it gets into nasal passages, it starts replicating very fast, and, when it replicates and reaches certain levels, it is able to move to other areas of the body, especially the lungs, where it creates havoc. We interrupt that process.”[i]
BioSURE PRO Protective Nasal Spray is now UKCA marked and MHRA registered. It is undergoing Notified Body CE marking for sales into Europe, with certification anticipated Q1 2023. The award winning formula is already proving successful in the USA under the Covixyl brand name 
For further information about BioSure, BioSURE PRO Nasal Spray or other products in the range, contact: email@example.com (Mble: 07710 774531) firstname.lastname@example.org
NOTE TO EDITORS: BioSURE Global Ltd: registered with MHRA and accredited with the EMA
BioSure Global develop, manufacture, source and distribute medical devices and rapid tests with the highest levels of accuracy, many rivalling those of standard laboratory tests. Its rapid diagnostic and detection tests are invaluable tools where immediate results are the primary consideration. The tests are used worldwide for the management of human infectious disease. BioSure Global specialise in providing solutions and has unique expertise in self testing. We passionately believe that this technology through integration into healthcare settings and for use as self tests can revolutionise testing protocols, reduce late diagnoses, provide cost effective testing solutions for the general population and engage hard to reach key populations. Ultimately budgets can be spread further through far lower delivery costs and immediate diagnosis.